Mike Lustgarten Tracks Biological Age and CVD Risk With His Second 2026 Blood Test
Researcher Mike Lustgarten analyzes his latest blood panel for biological age, cardiovascular risk, and diet correlations.
4,593 articles in this topic
Researcher Mike Lustgarten analyzes his latest blood panel for biological age, cardiovascular risk, and diet correlations.
Neuroscientist Tommy Wood joins Mike Lustgarten to break down the science of brain health, cognitive resilience, and longevity strategies.
Mike Lustgarten explores whether the Bortz biological age clock beats PhenoAge as a tool for measuring how fast you're aging.
Dr. Douglas Vaughan explains how the protein PAI-1 drives aging and how targeting it could extend healthy human lifespan.
Mike Lustgarten and Dr. Dan Winer explore how gut health directly influences aging, disease risk, and longevity strategies.
Biotech startup NewLimit is screening transcription factors to reverse cellular aging via partial reprogramming and mRNA delivery.
Bioinformatician David Meyer explains how stochastic DNA changes power aging clocks and what that means for rejuvenation.
KiraGen Bio is using multiplex gene editing and AI to build next-gen CAR-T therapies that could finally crack solid tumors like glioblastoma.
A UCSF researcher reveals that data access and reproducibility failures may be longevity science's biggest hidden bottleneck.
A Brazilian lab attempts to reproduce headline-making pig plasma rejuvenation results in rats — here's what they found.
Retro Biosciences used GPT-4b micro to engineer proteins that reverse cellular aging far more powerfully than evolution ever managed.
Public trust may be the missing ingredient for longevity advances. New cultural mapping reveals who believes — and who doesn't.